A Biotech Bash - Recs and Wrecks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : A Biotech Bash - Recs and Wrecks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (63)	8/28/1997 3:53:00 AM
From: scaram(o)uche	of 171

I'd be very interested, as long as I don't have to do any work. :-) I don't know anything about how the inhibitors actually work, what their mechanism of action is proposed to be. CytRx, bite my tongue, is also active here. Given their history, I doubt that the effort is backed by great science. We know that VRTX work is always based on sound science. Since Xenova hired Mike Ross from Arris to start their U.S. subsidiary, one has to assume that they also place a premium on decent modeling (although I don't know much about discrimination at the parent). I assume that anything from BCHE would be top-notch, but I don't actually know much about their scientists. A related area of interest could be new chemotherapies that are purported to work in cells that are multi-drug resistant (e.g., that in development by MGI Pharma?). Playing Peter............ Thanks, Miljenko.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next